These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 34054879)

  • 1. STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development.
    Filderman JN; Appleman M; Chelvanambi M; Taylor JL; Storkus WJ
    Front Immunol; 2021; 12():690105. PubMed ID: 34054879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment.
    Chelvanambi M; Fecek RJ; Taylor JL; Storkus WJ
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33526609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Tertiary Lymphoid Structures for Tumor Immunotherapy.
    Tang H; Qiu X; Timmerman C; Fu YX
    Methods Mol Biol; 2018; 1845():275-286. PubMed ID: 30141019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Endothelial Venules: A Vascular Perspective on Tertiary Lymphoid Structures in Cancer.
    Vella G; Guelfi S; Bergers G
    Front Immunol; 2021; 12():736670. PubMed ID: 34484246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tertiary lymphoid structures in the era of cancer immunotherapy.
    Sautès-Fridman C; Petitprez F; Calderaro J; Fridman WH
    Nat Rev Cancer; 2019 Jun; 19(6):307-325. PubMed ID: 31092904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining High Endothelial Venules and Tertiary Lymphoid Structures in Cancer.
    Jones E; Gallimore A; Ager A
    Methods Mol Biol; 2018; 1845():99-118. PubMed ID: 30141010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Induction of Tertiary Lymphoid Structures in Cancer Through Stromal Remodeling.
    Johansson-Percival A; Ganss R
    Front Immunol; 2021; 12():674375. PubMed ID: 34122434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tertiary Lymphoid Structures as a Predictive Biomarker of Response to Cancer Immunotherapies.
    Trüb M; Zippelius A
    Front Immunol; 2021; 12():674565. PubMed ID: 34054861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Tools for the Selective Visualization and Quantification of TLS-Immune Cells on Tissue Sections.
    Klein C; Devi-Marulkar P; Dieu-Nosjean MC; Germain C
    Methods Mol Biol; 2018; 1845():47-69. PubMed ID: 30141007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in Mice.
    Delvecchio FR; Fincham REA; Spear S; Clear A; Roy-Luzarraga M; Balkwill FR; Gribben JG; Bombardieri M; Hodivala-Dilke K; Capasso M; Kocher HM
    Cell Mol Gastroenterol Hepatol; 2021; 12(5):1543-1565. PubMed ID: 34252585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous Melanoma: Mutational Status and Potential Links to Tertiary Lymphoid Structure Formation.
    Salem D; Chelvanambi M; Storkus WJ; Fecek RJ
    Front Immunol; 2021; 12():629519. PubMed ID: 33746966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-Associated Tertiary Lymphoid Structures: From Basic and Clinical Knowledge to Therapeutic Manipulation.
    Domblides C; Rochefort J; Riffard C; Panouillot M; Lescaille G; Teillaud JL; Mateo V; Dieu-Nosjean MC
    Front Immunol; 2021; 12():698604. PubMed ID: 34276690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Crohn's-Like Lymphoid Reaction to Colorectal Cancer-Tertiary Lymphoid Structures With Immunologic and Potentially Therapeutic Relevance in Colorectal Cancer.
    Maoz A; Dennis M; Greenson JK
    Front Immunol; 2019; 10():1884. PubMed ID: 31507584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and Vascular Components of Tertiary Lymphoid Structures.
    Mueller CG; Nayar S; Gardner D; Barone F
    Methods Mol Biol; 2018; 1845():17-30. PubMed ID: 30141005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Programmed Cell Death on the Formation of Tertiary Lymphoid Structures.
    Dieudé M; Kaci I; Hébert MJ
    Front Immunol; 2021; 12():696311. PubMed ID: 34335608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tertiary lymphoid structures in cancer and beyond.
    Dieu-Nosjean MC; Goc J; Giraldo NA; Sautès-Fridman C; Fridman WH
    Trends Immunol; 2014 Nov; 35(11):571-80. PubMed ID: 25443495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating Tumor-Associated Tertiary Lymphoid Structures in Murine Lung Adenocarcinoma.
    Connolly KA; Nader M; Joshi N
    Methods Mol Biol; 2018; 1845():259-273. PubMed ID: 30141018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy.
    Groeneveld CS; Fontugne J; Cabel L; Bernard-Pierrot I; Radvanyi F; Allory Y; de Reyniès A
    Eur J Cancer; 2021 May; 148():181-189. PubMed ID: 33743486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Quantitative Pathology Approach to Analyze the Development of Human Cancer-Associated Tertiary Lymphoid Structures.
    Siliņa K; Burkhardt C; Casanova R; Solterman A; van den Broek M
    Methods Mol Biol; 2018; 1845():71-86. PubMed ID: 30141008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Standardized Analysis of Tertiary Lymphoid Structures in Human Melanoma: Disease Progression- and Tumor Site-Associated Changes With Germinal Center Alteration.
    Werner F; Wagner C; Simon M; Glatz K; Mertz KD; Läubli H; Griss J; Wagner SN
    Front Immunol; 2021; 12():675146. PubMed ID: 34248957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.